OUR LEADERS
Dr. Nupam Mahajan, PhD
President & CEO
Dr Nupam Mahajan is a Professor of Surgery, Director of Urological Research and an Endowed Professor of Cancer Research at Siteman Cancer Center, Washington University in St. Louis.
He has over a decade of experience in developing new classes of cancer drugs and taking the compounds into clinical trials. He has developed the compound (R)-9b which has completed extensive pre-IND studies and filed for IND. The clinical trials are expected to be in summer of 2024.
He is also inventor of 3 additional therapeutic molecules, each of which are in pre-IND stage and are undergoing extensive pre-clinical work. All three are expected to be into clinical trials.
Mr. Steve Nemeth
Founder Director
Mr Nemeth is a founder director of the company. He has over 2 decades of experience with working on various Wall Street Companies, including MS Farrell. His experience has been critical for development of TechnoGenesys as a therapeutic company with multiple IPs.
Dr. Flaherty, MD
Advisor
Dr Flaherty is expert in cancer therapeutics development and clinical trials.
